24.06.2024 13:15:52 - dpa-AFX: *BIONTECH, DUALITYBIO RECEIVE FDA FAST TRACK DESIGNATION FOR BNT324/DB-1311 IN PROSTATE CANCER

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
BIONTECH SE SPON. ADRS 1 A2PSR2 Frankfurt 75,150 10.07.24 16:35:39 +1,200 +1,62% 74,200 75,050 74,550 73,950

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH